獣医皮膚科市場 – 2030年までの世界予測

Report Overview

The global veterinary dermatology market is projected to reach USD 30.31 billion by 2030 from USD 20.11 billion in 2025, at a CAGR of 8.5% during the forecast period.

世界の獣医皮膚科市場は、予測期間中に8.5%のCAGRで成長し、2025年の201億1,000万米ドルから2030年までに303億1,000万米ドルに達すると予測されています。

The Veterinary Dermatology Market is experiencing significant growth, driven by the expanding companion animal population and increasing pet ownership. Growing concerns about infectious zoonotic diseases have further influenced the demand for dermatological treatments. Government and animal welfare organizations are actively promoting awareness initiatives, encouraging early diagnosis and treatment of dermatological conditions in both pets and farm animals. Moreover, the rising adoption of pet insurance and high animal healthcare expenditure are supporting market growth by improving access to specialized dermatological care. However, the market faces challenges such as the rising cost of pet care, which can limit treatment adoption. Additionally, increasing resistance to parasiticides poses a significant concern, reducing the effectiveness of common dermatological treatments. Despite these restraints, advancements in veterinary dermatology, including novel therapeutics and diagnostic techniques, continue to drive market opportunities.

獣医皮膚科市場は、ペットの飼育数の増加とペットの飼育数の増加に牽引され、著しい成長を遂げています。人獣共通感染症への懸念の高まりも、皮膚科治療の需要にさらなる影響を与えています。政府や動物福祉団体は、ペットと家畜の両方で皮膚疾患の早期診断と治療を奨励する啓発活動を積極的に推進しています。さらに、ペット保険の導入増加と動物医療費の高騰により、専門的な皮膚科医療へのアクセスが改善され、市場の成長を支えています。しかし、市場はペットケアのコスト上昇などの課題に直面しており、これが治療の導入を制限する可能性があります。さらに、寄生虫駆除剤に対する耐性の高まりが大きな懸念事項となっており、一般的な皮膚科治療の有効性が低下しています。これらの制約にもかかわらず、新しい治療法や診断技術を含む獣医皮膚科の進歩は、引き続き市場機会を促進しています。

“The Oral segment is projected to grow at the highest CAGR during the forecast period of 2025-2030.”

The oral segment is projected to grow at the highest CAGR during 2025-2030 due to its ease of administration and improved pet owner compliance. Oral medications, including tablets, capsules, and chewable formulations, offer a convenient alternative to topical and injectable treatments. Increasing veterinary recommendations for systemic treatments over topical solutions and the development of palatable formulations are boosting demand. Additionally, advancements in drug delivery systems, such as sustained-release oral formulations, contribute to the segment’s growth in the veterinary dermatology market.

“Antiparasitic Drugs segment accounted the largest market in 2024 in veterinary dermatology market.”

The antiparasitic drugs segment accounted for the largest market share in 2024 due to the rising prevalence of parasitic infections in animals. These drugs, including flea and tick preventives, are widely used for both treatment and prevention. Increasing pet adoption and awareness about zoonotic diseases are fueling the demand for antiparasitic treatments. Moreover, the growing availability of combination therapies that target multiple parasites has driven market expansion. Key industry players are launching innovative formulations with improved efficacy and longer protection durations, further strengthening the segment’s dominance.

” Parasitic infection is expected to witness the fastest growth rate in the global veterinary dermatology market.”

Parasitic infections are expected to witness the fastest growth rate in the veterinary dermatology market. The high incidence of flea, tick, and mite infestations in pets, especially in warm and humid regions, is driving demand for effective treatments. Parasitic dermatitis can cause severe itching, hair loss, and secondary bacterial infections, increasing the need for veterinary care. Advancements in diagnostic methods and increasing availability of prescription and over-the-counter treatments contribute to the segment’s rapid growth. Moreover, heightened pet owner awareness of parasite prevention further supports market expansion.

“Companion animals segment has accounted the largest market share in the veterinary dermatology market.”

The companion animals segment accounted for the largest market share in 2024, driven by increasing pet ownership and growing expenditure on animal healthcare. Dogs and cats are highly susceptible to skin conditions such as allergies, fungal infections, and ectoparasitic infestations, necessitating frequent dermatological treatments. The rising trend of pet humanization and demand for premium veterinary care further boost market growth. Additionally, advancements in dermatological therapeutics, including biologics and targeted therapies, enhance treatment outcomes for companion animals, reinforcing the segment’s dominance in the market.

“Veterinary Hospitals and Clinics segment is expected to witness the highest growth rate in the global veterinary dermatology market.”

Veterinary hospitals and clinics are expected to witness the highest growth rate, driven by the increasing number of veterinary visits and the availability of specialized dermatology services. These facilities provide comprehensive treatment options, including advanced diagnostics, prescription medications, and surgical interventions for severe skin conditions. The rise in dermatology-focused veterinary clinics and expansion of telemedicine services for dermatological consultations contribute to segment growth. Additionally, pet insurance coverage for dermatological treatments encourages pet owners to seek veterinary care, further increasing demand in this segment.

“North America has accounted for the largest market share in 2024.”

North America accounted for the largest market share in 2024, supported by a well-established veterinary healthcare infrastructure and high pet ownership rates. The region has a strong presence of leading market players investing in research and development for innovative dermatological treatments. Rising awareness about pet skin health, coupled with increasing spending on veterinary care, drives market expansion. Additionally, the growing demand for premium pet dermatology products, including hypoallergenic shampoos, medicated sprays, and prescription drugs, contributes to North America’s market dominance in the global veterinary dermatology industry.

Breakdown of supply-side primary interviews:

• • By Company Type: Tier 1 – 45%, Tier 2 – 20%, and Tier 3 – 35%
• • By Designation: C-level – 35%, Director-level – 25%, and Others – 40%
• • By Region: North America – 40%, Europe – 25%, APAC – 20%, Latin America – 10%, Middle East & Africa – 5%

Breakdown of demand-side primary interviews:

• • By Company Type: Vterinary Hospitals and Clinics – 55%, Animal Shelters and Clinics – 30%, and Other End Users – 15%
• • By Designation: Veterinary Professionals – 35%, Pet Owners – 30%, Livestock Farmers – 25% and Governtment Officers – 10%
• • By Region: North America – 40%, Europe – 25%, APAC – 20%, Latin America – 10%, Middle East & Africa – 5%

Research Coverage

This report studies veterinary dermatology market based on route of administration, product types, condition types, animal types, end users, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and respective countries.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

• Analysis of key drivers (Expanding companion animal population and pet ownership, Growing concerns about infectious zoonotic diseases, Rising Awareness initiatives by government and animal welfare organizations, Increasing adoption of pet insurance and high animal healthcare expenditure), restraints (Rising pet care costs, Restrictions on use of parasiticides for food-producing animals), opportunities (Technological advancements and product launches, High growth potential in emerging economies, Surging number of veterinary practitioners in developed markets), and challenges (Growing resistance to parasiticides, Diversity in parasite species) influencing the growth of veterinary dermatology market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in veterinary dermatology market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary dermatology treatments across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in veterinary dermatology market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in veterinary dermatology market.

Table of Contents

1               INTRODUCTION              32

1.1           STUDY OBJECTIVES       32

1.2           MARKET DEFINITION   33

1.2.1        INCLUSIONS AND EXCLUSIONS 33

1.3           STUDY SCOPE   34

1.3.1        YEARS CONSIDERED      35

1.4           CURRENCY CONSIDERED            35

1.5           STAKEHOLDERS               36

2               RESEARCH METHODOLOGY       37

2.1           RESEARCH APPROACH  37

2.1.1        SECONDARY DATA          38

2.1.1.1    Key data from secondary sources       40

2.1.2        PRIMARY DATA 40

2.1.2.1    Key data from primary sources           42

2.1.2.2    Key industry insights           43

2.2           MARKET SIZE ESTIMATION         45

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 51

2.4           MARKET SHARE ESTIMATION    51

2.5           RESEARCH ASSUMPTIONS           52

2.6           RISK ASSESSMENT           52

2.7           RESEARCH LIMITATIONS             53

2.7.1        METHODOLOGY-RELATED LIMITATIONS           53

2.7.2        SCOPE-RELATED LIMITATIONS                 53

3               EXECUTIVE SUMMARY  54

4               PREMIUM INSIGHTS       60

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VETERINARY DERMATOLOGY MARKET 60

4.2           NORTH AMERICA: VETERINARY DERMATOLOGY MARKET OVERVIEW       61

4.3           VETERINARY DERMATOLOGY MARKET: REGIONAL MIX                 62

4.4           VETERINARY DERMATOLOGY MARKET, BY COUNTRY                 62

4.5           VETERINARY DERMATOLOGY MARKET: EMERGING VS. DEVELOPED MARKETS 63

5               MARKET OVERVIEW       64

5.1           INTRODUCTION              64

5.2           MARKET DYNAMICS       65

5.2.1        DRIVERS               65

5.2.1.1    Expanding companion animal population and pet ownership                 65

5.2.1.2    Growing concerns about infectious zoonotic diseases    68

5.2.1.3    Rising awareness initiatives by government and animal welfare organizations         70

5.2.1.4    Increasing adoption of pet insurance and high animal healthcare expenditure            70

5.2.2        RESTRAINTS      72

5.2.2.1    Rising pet care costs             72

5.2.2.2    Restrictions on use of parasiticides for food-producing animals                 72

5.2.3        OPPORTUNITIES              73

5.2.3.1    Technological advancements and product launches       73

5.2.3.2    High growth potential in emerging economies                73

5.2.3.3    Surging number of veterinary practitioners in developed markets                 74

5.2.4        CHALLENGES    75

5.2.4.1    Growing resistance to parasiticides   75

5.2.4.2    Diversity in parasite species                76

5.3           INDUSTRY TRENDS         76

5.3.1        RISE IN PET OWNERSHIP, HUMANIZATION OF PETS, AND INCREASED FOCUS ON PET WELLNESS PROGRAMS                 76

5.3.2        RISING USE OF DIAGNOSTICS AND WEARABLE TECHNOLOGY FOR EARLY DETECTION                76

5.4           TECHNOLOGY ANALYSIS             77

5.4.1        KEY TECHNOLOGIES     77

5.4.1.1    Topical nanomedicine          77

5.4.1.2    Biologic therapies 77

5.4.2        COMPLEMENTARY TECHNOLOGIES       78

5.4.2.1    Phototherapy         78

5.4.2.2    Hydrotherapy        78

5.4.3        ADJACENT TECHNOLOGIES       78

5.4.3.1    Telemedicine platforms       79

5.4.3.2    Wearable devices  79

5.5           PORTER’S FIVE FORCES ANALYSIS           79

5.5.1        COMPETITIVE RIVALRY                 80

5.5.1.1    Established players               80

5.5.1.2    Continuous innovation        80

5.5.2        BARGAINING POWER OF BUYERS             80

5.5.2.1    Consolidated veterinary groups          80

5.5.2.2    Demand for affordable solutions       80

5.5.3        BARGAINING POWER OF SUPPLIERS       80

5.5.3.1    Specialized raw materials    80

5.5.3.2    Quality compliance               80

5.5.4        THREAT OF SUBSTITUTES          81

5.5.4.1    Limited alternatives              81

5.5.4.2    Specialized treatments         81

5.5.5        THREAT OF NEW ENTRANTS      81

5.5.5.1    High R&D costs   81

5.5.5.2    Regulatory requirements     81

5.6           REGULATORY LANDSCAPE         82

5.6.1        REGULATORY ANALYSIS               82

5.6.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             85

5.7           PATENT ANALYSIS          87

5.7.1        PATENT PUBLICATION TRENDS FOR VETERINARY DERMATOLOGY MARKET            87

5.7.2        INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            88

5.8           TRADE ANALYSIS             91

5.8.1        IMPORT AND EXPORT SCENARIO FOR VETERINARY DERMATOLOGY PRODUCTS      91

5.9           PRICING ANALYSIS          92

5.9.1        AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE                92

5.9.2        AVERAGE SELLING PRICE TREND OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION 93

5.10         REIMBURSEMENT ANALYSIS      95

5.11         KEY CONFERENCES AND EVENTS             96

5.12         KEY STAKEHOLDERS AND BUYING CRITERIA     97

5.12.1      KEY STAKEHOLDERS IN BUYING PROCESS           97

5.12.2      BUYING CRITERIA           97

5.13         UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET 98

5.14         IMPACT OF GENERATIVE AI ON VETERINARY DERMATOLOGY MARKET            99

5.15         ECOSYSTEM ANALYSIS  99

5.16         CASE STUDY ANALYSIS 101

5.16.1      ZOETIS LAUNCHED APOQUEL TABLET FOR ALLERGIC DERMATITIS      101

5.16.2      ELANCO LAUNCHED ZENRELIA TABLET FOR CANINE ATOPIC DERMATITIS     102

5.16.3      VIRBAC LAUNCHED ALLERDERM SPOT-ON TOPICAL PRODUCT FOR SKIN BARRIER REPAIR    102

5.17         SUPPLY CHAIN ANALYSIS             103

5.18         VALUE CHAIN ANALYSIS               104

5.19         ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET            105

5.20         TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            106

5.21         INVESTMENT AND FUNDING SCENARIO               107

6               VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION          108

6.1           INTRODUCTION              109

6.2           TOPICAL              109

6.2.1        HIGH PREVALENCE OF ECTOPARASITIC INFESTATIONS AMONG PETS TO DRIVE DEMAND           109

6.3           INJECTABLES    113

6.3.1        RAPID ABSORPTION AND HIGH BIOAVAILABILITY TO FUEL GROWTH OF INJECTABLE PRODUCTS       113

6.4           ORAL     115

6.4.1        COMPREHENSIVE APPROACH TO MANAGING CHRONIC AND SEVERE DERMATOLOGICAL DISORDERS   115

7               VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE     117

7.1           INTRODUCTION              118

7.2           ANTIPARASITIC DRUGS                 118

7.2.1        HIGH PREVALENCE OF PARASITIC INFECTIONS IN ANIMALS TO DRIVE DEMAND   118

7.3           ANTIFUNGAL DRUGS    122

7.3.1        INCREASING INSTANCES OF YEAST DERMATITIS AND CANDIDIASIS TO DRIVE DEMAND            122

7.4           ANTIBACTERIAL DRUGS               125

7.4.1        GROWTH HINDERED BY RISING CONCERNS OVER ANTIMICROBIAL RESISTANCE   125

7.5           MONOCLONAL ANTIBODIES     127

7.5.1        RISING INVESTMENT IN R&D TO BOOST SEGMENTAL GROWTH             127

7.6           OTHER PRODUCT TYPES             129

8               VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE     131

8.1           INTRODUCTION              132

8.2           PARASITIC INFECTIONS                132

8.2.1        HIGH OCCURRENCE IN BOTH COMPANION AND LIVESTOCK ANIMALS TO DRIVE DEMAND FOR PREVENTIVE MEASURES          132

8.3           INFECTIOUS DISEASES 134

8.3.1        HIGH PREVALENCE OF FUNGAL INFECTIONS TO DRIVE GROWTH             134

8.4           AUTOIMMUNE SKIN DISEASES  136

8.4.1        LOWER OCCURRENCE OF THESE DISEASES CONTRIBUTE TO SMALLER MARKET SHARE       136

8.5           SKIN CANCER    138

8.5.1        GROWING AWARENESS ABOUT IMPORTANCE OF EARLY DETECTION AND TREATMENT OF SKIN CANCER TO DRIVE GROWTH             138

8.6           OTHER CONDITION TYPES         140

9               VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE     142

9.1           INTRODUCTION              143

9.2           COMPANION ANIMALS 143

9.2.1        DOGS    146

9.2.1.1    Growing dog population and high pet ownership to drive growth                 146

9.2.2        CATS     148

9.2.2.1    Growing awareness of feline health to drive growth       148

9.2.3        HORSES                150

9.2.3.1    Initiatives related to adoption to drive growth 150

9.2.4        OTHER COMPANION ANIMALS 152

9.3           LIVESTOCK ANIMALS    154

9.3.1        CATTLE                156

9.3.1.1    Economic importance of dairy and beef cattle to drive growth                 156

9.3.2        SWINE  158

9.3.2.1    Rising global swine population and pork consumption to drive growth    158

9.3.3        POULTRY             160

9.3.3.1    Increasing demand for milk and dairy products to drive growth                 160

9.3.4        OTHER LIVESTOCK ANIMALS    162

10            VETERINARY DERMATOLOGY MARKET, BY END USER                 164

10.1         INTRODUCTION              165

10.2         VETERINARY HOSPITALS AND CLINICS 165

10.2.1      GROWING DEMAND FOR SPECIALIZED SKINCARE AND TREATMENTS TO DRIVE MARKET            165

10.3         ANIMAL SHELTERS AND RESCUES            167

10.3.1      NGO AND ANIMAL WELFARE ORGANIZATIONS TO KEEP SUPPORTING DERMATOLOGICAL TREATMENT IN VETERINARY MARKET               167

10.4         OTHER END USERS         169

11            VETERINARY DERMATOLOGY MARKET, BY REGION                 171

11.1         INTRODUCTION              172

11.2         NORTH AMERICA             173

11.2.1      MACROECONOMIC OUTLOOK  173

11.2.2      US           179

11.2.2.1  High pet ownership rates to drive growth        179

11.2.3      CANADA               183

11.2.3.1  Rising concerns about pet skin health to drive market   183

11.3         EUROPE               187

11.3.1      MACROECONOMIC OUTLOOK  187

11.3.2      GERMANY           192

11.3.2.1  Rising poultry consumption and dairy industry to drive market                 192

11.3.3      UK          196

11.3.3.1  Large pet ownership and zoonotic disease prevention to drive market    196

11.3.4      FRANCE                200

11.3.4.1  Stable animal healthcare spending to support market growth                 200

11.3.5      ITALY    203

11.3.5.1  Expanding livestock industry to drive market  203

11.3.6      SWITZERLAND 206

11.3.6.1  High standards in animal health to drive growth             206

11.3.7      SPAIN    210

11.3.7.1  Growing pet population and strong dairy industry to drive market                 210

11.3.8      REST OF EUROPE             213

11.4         ASIA PACIFIC     217

11.4.1      MACROECONOMIC OUTLOOK  217

11.4.2      JAPAN   223

11.4.2.1  Rising demand for animal products and increasing pet ownership to drive growth      223

11.4.3      CHINA  227

11.4.3.1  Expanding urban pet market and high meat consumption to fuel market    227

11.4.4      INDIA    231

11.4.4.1  Growing pet adoption and veterinary shortage to drive market                 231

11.4.5      AUSTRALIA         235

11.4.5.1  Growing pet ownership and rising spending on veterinary care to drive market          235

11.4.6      NEW ZEALAND 238

11.4.6.1  Increased pet ownership and demand for advanced dermatology treatments to drive market 238

11.4.7      SOUTH KOREA  242

11.4.7.1  Increasing awareness and adoption of preventive healthcare measures to drive market    242

11.4.8      REST OF ASIA PACIFIC   245

11.5         LATIN AMERICA                249

11.5.1      MACROECONOMIC OUTLOOK  249

11.5.2      BRAZIL 254

11.5.2.1  Strong veterinary infrastructure and expanding livestock industry to drive market      254

11.5.3      MEXICO                258

11.5.3.1  Expanding livestock and poultry sectors to drive market                 258

11.5.4      REST OF LATIN AMERICA             261

11.6         MIDDLE EAST & AFRICA                264

11.6.1      MACROECONOMIC OUTLOOK  264

11.6.2      GCC COUNTRIES              268

11.6.2.1  Kingdom of Saudi Arabia (KSA)        271

11.6.2.1.1                Vision 2030 investments to drive market          271

11.6.2.2  United Arab Emirates (UAE)             274

11.6.2.2.1                Significant livestock population to fuel demand                 274

11.6.2.3  Rest of GCC Countries        277

11.6.3      REST OF MIDDLE EAST & AFRICA             280

12            COMPETITIVE LANDSCAPE         284

12.1         OVERVIEW          284

12.2         KEY PLAYER STRATEGY/RIGHT TO WIN                284

12.3         REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020–2024)     285

12.4         MARKET SHARE ANALYSIS, 2024                 286

12.4.1      RANKING OF KEY MARKET PLAYERS, 2024             289

12.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 289

12.5.1      STARS   289

12.5.2      EMERGING LEADERS     289

12.5.3      PERVASIVE PLAYERS      289

12.5.4      PARTICIPANTS 290

12.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         291

12.5.5.1  Company footprint               291

12.5.5.2  Region footprint   292

12.5.5.3  Route of administration footprint      293

12.5.5.4  Product type footprint         294

12.5.5.5  Condition type footprint     295

12.5.5.6  Animal type footprint           296

12.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        297

12.6.1      PROGRESSIVE COMPANIES         297

12.6.2      RESPONSIVE COMPANIES            297

12.6.3      DYNAMIC COMPANIES  297

12.6.4      STARTING BLOCKS         297

12.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 299

12.7         BRAND/PRODUCT COMPARISON             301

12.8         R&D EXPENDITURE OF KEY PLAYERS     302

12.9         COMPANY VALUATION AND FINANCIAL METRICS                 302

12.9.1      COMPANY VALUATION 302

12.9.2      FINANCIAL METRICS      303

12.10       COMPETITIVE SCENARIO             303

12.10.1   PRODUCT APPROVALS/LAUNCHES         303

12.10.2   DEALS  304

12.10.3   EXPANSIONS     305

12.10.4   OTHER DEVELOPMENTS              306

13            COMPANY PROFILES      307

13.1         KEY PLAYERS     307

13.1.1      ELANCO ANIMAL HEALTH INCORPORATED       307

13.1.1.1  Business overview 307

13.1.1.2  Products offered   308

13.1.1.3  Recent developments           310

13.1.1.3.1                Product launches and approvals         310

13.1.1.3.2                Deals      310

13.1.1.3.3                Expansions             311

13.1.1.4  MnM view              311

13.1.1.4.1                Right to win           311

13.1.1.4.2                Strategic choices   311

13.1.1.4.3                Weaknesses and competitive threats 312

13.1.2      MERCK & CO., INC           313

13.1.2.1  Business overview 313

13.1.2.2  Products offered   314

13.1.2.3  Recent developments           315

13.1.2.3.1                Product launches and approvals         315

13.1.2.3.2                Deals      316

13.1.2.3.3                Expansions             317

13.1.2.3.4                Other developments             317

13.1.2.4  MnM view              317

13.1.2.4.1                Right to win           317

13.1.2.4.2                Strategic choices   318

13.1.2.4.3                Weaknesses and competitive threats 318

13.1.3      VIRBAC 319

13.1.3.1  Business overview 319

13.1.3.2  Products offered   320

13.1.3.3  Recent developments           321

13.1.3.3.1                Deals      321

13.1.3.3.2                Expansions             322

13.1.3.3.3                Other developments             322

13.1.3.4  MnM view              322

13.1.3.4.1                Right to win           322

13.1.3.4.2                Strategic choices   323

13.1.3.4.3                Weaknesses and competitive threats 323

13.1.4      ZOETIS INC.       324

13.1.4.1  Business overview 324

13.1.4.2  Products offered   325

13.1.4.3  Recent developments           326

13.1.4.3.1                Product launches and approvals         326

13.1.4.3.2                Deals      327

13.1.4.3.3                Expansions             327

13.1.4.3.4                Other developments             328

13.1.4.4  MnM view              328

13.1.4.4.1                Right to win           328

13.1.4.4.2                Strategic choices   328

13.1.4.4.3                Weaknesses and competitive threats 329

13.1.5      BOEHRINGER INGELHEIM INTERNATIONAL GMBH                 330

13.1.5.1  Business overview 330

13.1.5.2  Products offered   331

13.1.5.3  Recent developments           332

13.1.5.3.1                Product approvals 332

13.1.5.3.2                Deals      332

13.1.5.4  MnM view              332

13.1.5.4.1                Right to win           332

13.1.5.4.2                Strategic choices   333

13.1.5.4.3                Weaknesses and competitive threats 333

13.1.6      VETOQUINOL   334

13.1.6.1  Business overview 334

13.1.6.2  Products offered   335

13.1.6.3  Recent developments           336

13.1.6.3.1                Product approvals 336

13.1.7      DECHRA PHARMACEUTICALS PLC           337

13.1.7.1  Business overview 337

13.1.7.2  Products offered   338

13.1.7.3  Recent developments           339

13.1.7.3.1                Product approvals 339

13.1.7.3.2                Deals      340

13.1.8      HESTER BIOSCIENCES LIMITED                341

13.1.8.1  Business overview 341

13.1.8.2  Products offered   343

13.1.9      PETIQ, INC.         344

13.1.9.1  Business overview 344

13.1.9.2  Products offered   345

13.1.9.3  Recent developments           346

13.1.9.3.1                Other developments             346

13.1.10   OUROFINO SAUDE ANIMAL        347

13.1.10.1                 Business overview 347

13.1.10.2                 Products offered   348

13.1.11   SWEDENCARE   349

13.1.11.1                 Business overview 349

13.1.11.2                 Products offered   350

13.1.11.3                 Recent developments           351

13.1.11.3.1             Deals      351

13.1.12   ORION CORPORATION 353

13.1.12.1                 Business overview 353

13.1.12.2                 Products offered   354

13.1.13   NORBROOK        355

13.1.13.1                 Business overview 355

13.1.13.2                 Products offered   356

13.1.13.3                 Recent developments           357

13.1.13.3.1             Product launches  357

13.1.13.3.2             Expansions             358

13.1.14   CEVA SANTE ANIMALE  359

13.1.14.1                 Business overview 359

13.1.14.2                 Products offered   359

13.1.14.3                 Recent developments           360

13.1.14.3.1             Deals      360

13.1.15   BIMEDA, INC.     361

13.1.15.1                 Business overview 361

13.1.15.2                 Products offered   361

13.1.15.3                 Recent developments           362

13.1.15.3.1             Product launches  362

13.1.15.3.2             Deals      362

13.2         OTHER PLAYERS              363

13.2.1      INDIAN IMMUNOLOGICALS LTD.             363

13.2.2      VETANCO            364

13.2.3      CHANELLE PHARMA       365

13.2.4      PEGASUS LABORATORIES, INC. 366

13.2.5      KYORITSU SEIYAKU CORPORATION        367

13.2.6      AVET HEALTH   368

13.2.7      ANIMALDERMA SRLS     369

13.2.8      LETI PHARMA    370

13.2.9      HUVEPHARMA, INC.       371

13.2.10   VETPLUS              372

14            APPENDIX           373

14.1         DISCUSSION GUIDE        373

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                381

14.3         CUSTOMIZATION OPTIONS        383

14.4         RELATED REPORTS         383

14.5         AUTHOR DETAILS           384

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 35

TABLE 2                PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2024 66

TABLE 3                COMPANION ANIMAL POPULATION STATISTICS, BY REGION               67

TABLE 4                MAJOR OUTBREAKS OF ZOONOTIC DISEASES, 2022–2023              69

TABLE 5                AVERAGE ANNUAL PREMIUM: US AND CANADA (USD)    71

TABLE 6                VETERINARY DERMATOLOGY MARKET: IMPACT OF PORTER’S FIVE FORCES ANALYSIS  79

TABLE 7                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 85

TABLE 8                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           86

TABLE 9                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 87

TABLE 10              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 87

TABLE 11              VETERINARY DERMATOLOGY MARKET: LIST OF MAJOR PATENTS              90

TABLE 12              IMPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY,

BY COUNTRY (2022–2024) (USD)                91

TABLE 13              EXPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY,

BY COUNTRY (2022–2024) (USD)                91

TABLE 14              AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE,

2022–2024              93

TABLE 15              AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES,

BY REGION, 2022–2024    94

TABLE 16              VETERINARY DERMATOLOGY MARKET: KEY CONFERENCES AND EVENTS (2025−2026)             96

TABLE 17              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE    97

TABLE 18              KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS      98

TABLE 19              UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET 98

TABLE 20              VETERINARY DERMATOLOGY MARKET: IMPACT OF GENERATIVE AI       99

TABLE 21              VETERINARY DERMATOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 100

TABLE 22              VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            109

TABLE 23              VETERINARY DERMATOLOGY MARKET: TOPICAL PRODUCTS AVAILABLE             110

TABLE 24              TOPICAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY/REGION,

2023–2030 (USD MILLION)            112

TABLE 25              VETERINARY DERMATOLOGY MARKET: INJECTABLE PRODUCTS AVAILABLE      113

TABLE 26              INJECTABLES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 27              VETERINARY DERMATOLOGY MARKET: ORAL PRODUCTS AVAILABLE 115

TABLE 28              ORAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            116

TABLE 29              VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            118

TABLE 30              VETERINARY DERMATOLOGY MARKET: ANTIPARASITIC DRUGS AVAILABLE        119

TABLE 31              VOLUME DATA FOR ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)      120

TABLE 32              ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            121

TABLE 33              VETERINARY DERMATOLOGY MARKET: ANTIFUNGAL DRUGS AVAILABLE            122

TABLE 34              ANTIFUNGAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            124

TABLE 35              VETERINARY DERMATOLOGY MARKET: ANTIBACTERIAL DRUGS AVAILABLE      125

TABLE 36              ANTIBACTERIAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            126

TABLE 37              VETERINARY DERMATOLOGY MARKET: MONOCLONAL ANTIBODIES AVAILABLE              127

TABLE 38              MONOCLONAL ANTIBODIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            128

TABLE 39              VETERINARY DERMATOLOGY MARKET: OTHER PRODUCTS AVAILABLE 129

TABLE 40              OTHER PRODUCT TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            130

TABLE 41              VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            132

TABLE 42              PARASITIC INFECTIONS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            133

TABLE 43              INFECTIOUS DISEASES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            135

TABLE 44              AUTOIMMUNE SKIN DISEASES: VETERINARY DERMATOLOGY MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 45              SKIN CANCER: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            139

TABLE 46              OTHER CONDITION TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            141

TABLE 47              VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            143

TABLE 48              COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET,

2023–2030 (USD MILLION)            144

TABLE 49              COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            145

TABLE 50              DOGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            147

TABLE 51              CATS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            149

TABLE 52              HORSES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            151

TABLE 53              OTHER COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               153

TABLE 54              LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            155

TABLE 55              CATTLE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            157

TABLE 56              SWINE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            159

TABLE 57              POULTRY: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            161

TABLE 58              OTHER LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            163

TABLE 59              VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)                165

TABLE 60              VETERINARY HOSPITALS AND CLINICS: VETERINARY DERMATOLOGY MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               166

TABLE 61              ANIMAL SHELTERS AND RESCUES: VETERINARY DERMATOLOGY MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               168

TABLE 62              OTHER END USERS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            170

TABLE 63              VETERINARY DERMATOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION)          173

TABLE 64              NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            176

TABLE 65              NORTH AMERICA: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 176

TABLE 66              NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            177

TABLE 67              NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 177

TABLE 68              NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            178

TABLE 69              NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 178

TABLE 70              NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 179

TABLE 71              NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            179

TABLE 72              US: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            180

TABLE 73              US: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            181

TABLE 74              US: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            181

TABLE 75              US: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            182

TABLE 76              US: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            182

TABLE 77              US: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            182

TABLE 78              US: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            183

TABLE 79              CANADA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            184

TABLE 80              CANADA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            184

TABLE 81              CANADA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            185

TABLE 82              CANADA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            185

TABLE 83              CANADA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            186

TABLE 84              CANADA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            186

TABLE 85              CANADA: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            187

TABLE 86              EUROPE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 87              EUROPE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            189

TABLE 88              EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            190

TABLE 89              EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            190

TABLE 90              EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            191

TABLE 91              EUROPE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            191

TABLE 92              EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            192

TABLE 93              EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            192

TABLE 94              GERMANY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            193

TABLE 95              GERMANY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            193

TABLE 96              GERMANY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            194

TABLE 97              GERMANY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            194

TABLE 98              GERMANY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)                 195

TABLE 99              GERMANY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            195

TABLE 100            GERMANY: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            196

TABLE 101            UK: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION,

2023–2030 (USD MILLION)            197

TABLE 102            UK: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            197

TABLE 103            UK: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            198

TABLE 104            UK: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            198

TABLE 105            UK: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            199

TABLE 106            UK: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            199

TABLE 107            UK: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            200

TABLE 108            FRANCE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            200

TABLE 109            FRANCE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            201

TABLE 110            FRANCE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            201

TABLE 111            FRANCE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            202

TABLE 112            FRANCE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            202

TABLE 113            FRANCE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            203

TABLE 114            FRANCE: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            203

TABLE 115            ITALY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 204

TABLE 116            ITALY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            204

TABLE 117            ITALY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            205

TABLE 118            ITALY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            205

TABLE 119            ITALY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            205

TABLE 120            ITALY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            206

TABLE 121            ITALY: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            206

TABLE 122            SWITZERLAND: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 207

TABLE 123            SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            207

TABLE 124            SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            208

TABLE 125            SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            208

TABLE 126            SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)                 209

TABLE 127            SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)                 209

TABLE 128            SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            210

TABLE 129            SPAIN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 210

TABLE 130            SPAIN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            211

TABLE 131            SPAIN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            211

TABLE 132            SPAIN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            212

TABLE 133            SPAIN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            212

TABLE 134            SPAIN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            213

TABLE 135            SPAIN: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            213

TABLE 136            REST OF EUROPE: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 214

TABLE 137            REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            214

TABLE 138            REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 215

TABLE 139            REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            215

TABLE 140            REST OF EUROPE: VETERINARY DERMATOLOGY MARKET,

BY COMPANION ANIMALS, 2023–2030 (USD MILLION)     216

TABLE 141            REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 216

TABLE 142            REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            217

TABLE 143            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            220

TABLE 144            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 220

TABLE 145            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            221

TABLE 146            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            221

TABLE 147            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            222

TABLE 148            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)                 222

TABLE 149            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)                 223

TABLE 150            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            223

TABLE 151            JAPAN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 224

TABLE 152            JAPAN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            224

TABLE 153            JAPAN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            225

TABLE 154            JAPAN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            225

TABLE 155            JAPAN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            226

TABLE 156            JAPAN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            226

TABLE 157            JAPAN: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            227

TABLE 158            CHINA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 228

TABLE 159            CHINA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            228

TABLE 160            CHINA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            229

TABLE 161            CHINA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            229

TABLE 162            CHINA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            230

TABLE 163            CHINA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            230

TABLE 164            CHINA: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            231

TABLE 165            INDIA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 232

TABLE 166            INDIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            232

TABLE 167            INDIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            233

TABLE 168            INDIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            233

TABLE 169            INDIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            234

TABLE 170            INDIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            234

TABLE 171            INDIA: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            235

TABLE 172            AUSTRALIA: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 235

TABLE 173            AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            236

TABLE 174            AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            236

TABLE 175            AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            237

TABLE 176            AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)                 237

TABLE 177            AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)                 238

TABLE 178            AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            238

TABLE 179            NEW ZEALAND: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 239

TABLE 180            NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            239

TABLE 181            NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)                 240

TABLE 182            NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            240

TABLE 183            NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)                 241

TABLE 184            NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)                 241

TABLE 185            NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            242

TABLE 186            SOUTH KOREA: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 242

TABLE 187            SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            243

TABLE 188            SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            243

TABLE 189            SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            244

TABLE 190            SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)                 244

TABLE 191            SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)                 245

TABLE 192            SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            245

TABLE 193            REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 246

TABLE 194            REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)            246

TABLE 195            REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 247

TABLE 196            REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            247

TABLE 197            REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET,

BY COMPANION ANIMALS, 2023–2030 (USD MILLION)     248

TABLE 198            REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET,

BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)        248

TABLE 199            REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            249

TABLE 200            LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            250

TABLE 201            LATIN AMERICA: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 251

TABLE 202            LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            251

TABLE 203            LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)                 252

TABLE 204            LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            252

TABLE 205            LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)                 253

TABLE 206            LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)                 253

TABLE 207            LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            254

TABLE 208          BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 255

TABLE 209          BRAZIL: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            255

TABLE 210          BRAZIL: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            256

TABLE 211          BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            256

TABLE 212          BRAZIL: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            257

TABLE 213          BRAZIL: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            257

TABLE 214          BRAZIL: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            258

TABLE 215            MEXICO: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)            258

TABLE 216            MEXICO: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            259

TABLE 217            MEXICO: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            259

TABLE 218            MEXICO: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            260

TABLE 219            MEXICO: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            260

TABLE 220            MEXICO: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            260

TABLE 221            MEXICO: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            261

TABLE 222            REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 261

TABLE 223            REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET,

BY PRODUCT TYPE, 2023–2030 (USD MILLION)  262

TABLE 224            REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET,

BY CONDITION TYPE, 2023–2030 (USD MILLION)               262

TABLE 225            REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            263

TABLE 226            REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET,

BY COMPANION ANIMALS, 2023–2030 (USD MILLION)     263

TABLE 227            REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET,

BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)        263

TABLE 228            REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            264

TABLE 229            MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            265

TABLE 230            MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 265

TABLE 231            MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY CONDITION TYPE, 2023–2030 (USD MILLION)               266

TABLE 232            MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION)            266

TABLE 233            MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY COMPANION ANIMALS, 2023–2030 (USD MILLION)     267

TABLE 234            MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)        267

TABLE 235            MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION)            267

TABLE 236            GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            268

TABLE 237            GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 268

TABLE 238            GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)                 269

TABLE 239            GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION)                 269

TABLE 240            GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            270

TABLE 241            GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION)                 270

TABLE 242            GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)                 270

TABLE 243            GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            271

TABLE 244            KSA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 271

TABLE 245            KSA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            272

TABLE 246            KSA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            272

TABLE 247            KSA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            273

TABLE 248            KSA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            273

TABLE 249            KSA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            273

TABLE 250            KSA: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            274

TABLE 251            UAE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 274

TABLE 252            UAE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE,

2023–2030 (USD MILLION)            275

TABLE 253            UAE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2023–2030 (USD MILLION)            275

TABLE 254            UAE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2023–2030 (USD MILLION)            276

TABLE 255            UAE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS,

2023–2030 (USD MILLION)            276

TABLE 256            UAE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS,

2023–2030 (USD MILLION)            276

TABLE 257            UAE: VETERINARY DERMATOLOGY MARKET, BY END USER,

2023–2030 (USD MILLION)            277

TABLE 258            REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 277

TABLE 259            REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET,

BY PRODUCT TYPE, 2023–2030 (USD MILLION)  278

TABLE 260            REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET,

BY CONDITION TYPE, 2023–2030 (USD MILLION)               278

TABLE 261            REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       279

TABLE 262            REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET,

BY COMPANION ANIMALS, 2023–2030 (USD MILLION)     279

TABLE 263            REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET,

BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)        279

TABLE 264            REST OF GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET,

BY END USER, 2023–2030 (USD MILLION)               280

TABLE 265            REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)                 280

TABLE 266            REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY PRODUCT TYPE, 2023–2030 (USD MILLION)  281

TABLE 267            REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY CONDITION TYPE, 2023–2030 (USD MILLION)               281

TABLE 268            REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY ANIMAL TYPE, 2023–2030 (USD MILLION)       282

TABLE 269            REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY COMPANION ANIMALS, 2023–2030 (USD MILLION)     282

TABLE 270            REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION)        282

TABLE 271            REST OF MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET,

BY END USER, 2023–2030 (USD MILLION)               283

TABLE 272            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET        284

TABLE 273            VETERINARY DERMATOLOGY MARKET: DEGREE OF COMPETITION         287

TABLE 274            VETERINARY DERMATOLOGY MARKET: REGION FOOTPRINT     292

TABLE 275            VETERINARY DERMATOLOGY MARKET: ROUTE OF ADMINISTRATION FOOTPRINT          293

TABLE 276            VETERINARY DERMATOLOGY MARKET: PRODUCT TYPE FOOTPRINT     294

TABLE 277            VETERINARY DERMATOLOGY MARKET: CONDITION TYPE FOOTPRINT 295

TABLE 278            VETERINARY DERMATOLOGY MARKET: ANIMAL TYPE FOOTPRINT          296

TABLE 279            VETERINARY DERMATOLOGY MARKET: LIST OF KEY STARTUPS/SMES    299

TABLE 280            VETERINARY DERMATOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES    300

TABLE 281            VETERINARY DERMATOLOGY MARKET: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021–JANUARY 2025        303

TABLE 282            VETERINARY DERMATOLOGY MARKET: DEALS, JANUARY 2021–JANUARY 2025     304

TABLE 283            VETERINARY DERMATOLOGY MARKET: EXPANSIONS,

JANUARY 2021–JANUARY 2025     305

TABLE 284            VETERINARY DERMATOLOGY MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     306

TABLE 285            ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW   307

TABLE 286            ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED    308

TABLE 287            ELANCO ANIMAL HEALTH INCORPORATED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–JANUARY 2025    310

TABLE 288            ELANCO ANIMAL HEALTH INCORPORATED: DEALS, JANUARY 2021–JANUARY 2025      310

TABLE 289            ELANCO ANIMAL HEALTH INCORPORATED: EXPANSIONS,

JANUARY 2021–JANUARY 2025     311

TABLE 290            MERCK & CO., INC: COMPANY OVERVIEW                 313

TABLE 291            MERCK & CO., INC: PRODUCTS OFFERED                 314

TABLE 292            MERCK & CO., INC: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–JANUARY 2025     315

TABLE 293            MERCK & CO., INC: DEALS, JANUARY 2021–JANUARY 2025    316

TABLE 294            MERCK & CO., INC: EXPANSIONS, JANUARY 2021–JANUARY 2025    317

TABLE 295            MERCK & CO., INC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     317

TABLE 296            VIRBAC: COMPANY OVERVIEW 319

TABLE 297            VIRBAC: PRODUCTS OFFERED  320

TABLE 298            VIRBAC: DEALS, JANUARY 2021–JANUARY 2025                 321

TABLE 299            VIRBAC: EXPANSIONS, JANUARY 2021–JANUARY 2025        322

TABLE 300            VIRBAC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025         322

TABLE 301            ZOETIS INC.: COMPANY OVERVIEW        324

TABLE 302            ZOETIS INC.: PRODUCTS OFFERED         325

TABLE 303            ZOETIS INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021–JANUARY 2025     326

TABLE 304            ZOETIS INC.: DEALS, JANUARY 2021–JANUARY 2025        327

TABLE 305            ZOETIS INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025    327

TABLE 306            ZOETIS INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     328

TABLE 307            BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW    330

TABLE 308            BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED     331

TABLE 309            BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025                 332

TABLE 310            BOEHRINGER INGELHEIM INTERNATIONAL GMBH: DEALS,

JANUARY 2021–JANUARY 2025     332

TABLE 311            VETOQUINOL: COMPANY OVERVIEW    334

TABLE 312            VETOQUINOL: PRODUCTS OFFERED     335

TABLE 313            VETOQUINOL: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025     336

TABLE 314            DECHRA PHARMACEUTICALS PLC: COMPANY OVERVIEW          337

TABLE 315            DECHRA PHARMACEUTICALS PLC: PRODUCTS OFFERED             338

TABLE 316            DECHRA PHARMACEUTICALS PLC: PRODUCT APPROVALS,

JANUARY 2021–JANUARY 2025     339

TABLE 317            DECHRA PHARMACEUTICALS PLC: DEALS, JANUARY 2021–JANUARY 2025     340

TABLE 318            HESTER BIOSCIENCES LIMITED: COMPANY OVERVIEW          341

TABLE 319            HESTER BIOSCIENCES LIMITED: PRODUCTS OFFERED             343

TABLE 320            PETIQ, INC.: COMPANY OVERVIEW         344

TABLE 321            PETIQ, INC.: PRODUCTS OFFERED          345

TABLE 322            PETIQ, INC.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025         346

TABLE 323            OUROFINO SAUDE ANIMAL: COMPANY OVERVIEW          347

TABLE 324            OUROFINO SAUDE ANIMAL: PRODUCTS OFFERED             348

TABLE 325            SWEDENCARE: COMPANY OVERVIEW    349

TABLE 326            SWEDENCARE: PRODUCTS OFFERED     350

TABLE 327            SWEDENCARE: DEALS, JANUARY 2021–JANUARY 2025        351

TABLE 328            ORION CORPORATION: COMPANY OVERVIEW                 353

TABLE 329            ORION CORPORATION: PRODUCTS OFFERED                 354

TABLE 330            NORBROOK: COMPANY OVERVIEW         355

TABLE 331            NORBROOK: PRODUCTS OFFERED          356

TABLE 332            NORBROOK: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025         357

TABLE 333            NORBROOK: EXPANSIONS, JANUARY 2021–JANUARY 2025    358

TABLE 334            CEVA SANTE ANIMALE: COMPANY OVERVIEW                 359

TABLE 335            CEVA SANTE ANIMALE: PRODUCTS OFFERED                 359

TABLE 336            CEVA SANTE ANIMALE: DEALS, JANUARY 2021–JANUARY 2025    360

TABLE 337            BIMEDA, INC.: COMPANY OVERVIEW     361

TABLE 338            BIMEDA, INC.: PRODUCTS OFFERED      361

TABLE 339            BIMEDA, INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025         362

TABLE 340            BIMEDA, INC.: DEALS, JANUARY 2021–JANUARY 2025        362

LIST OF FIGURES

FIGURE 1              VETERINARY DERMATOLOGY MARKET SCOPE AND REGIONS COVERED              34

FIGURE 2              RESEARCH DESIGN         37

FIGURE 3              PRIMARY SOURCES         41

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS            43

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                44

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION                 44

FIGURE 7              SUPPLY-SIDE MARKET SIZE ESTIMATION                 45

FIGURE 8             REVENUE ESTIMATION APPROACH: ZOETIS INC.                 46

FIGURE 9              VETERINARY DERMATOLOGY MARKET (2024): SUPPLY-SIDE ANALYSIS                 47

FIGURE 10            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2030)          48

FIGURE 11            CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS                 49

FIGURE 12            TOP-DOWN APPROACH                49

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 51

FIGURE 14            VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION,

2025 VS. 2030 (USD MILLION)      54

FIGURE 15            VETERINARY DERMATOLOGY MARKET, BY PRODUCT,

2025 VS. 2030 (USD MILLION)      55

FIGURE 16            VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE,

2025 VS. 2030 (USD MILLION)      55

FIGURE 17            VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE,

2025 VS. 2030 (USD MILLION)      56

FIGURE 18            VETERINARY DERMATOLOGY MARKET FOR COMPANION ANIMALS,

2025 VS. 2030 (USD MILLION)      57

FIGURE 19            VETERINARY DERMATOLOGY MARKET FOR LIVESTOCK ANIMALS,

2025 VS. 2030 (USD MILLION)      57

FIGURE 20            VETERINARY DERMATOLOGY MARKET, BY END USER,

2025 VS. 2030 (USD MILLION)      58

FIGURE 21            GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS HIGHEST

GROWTH RATE DURING FORECAST PERIOD      59

FIGURE 22            RISING PET POPULATION AND OWNERSHIP TO DRIVE VETERINARY

DERMATOLOGY MARKET            60

FIGURE 23            ANTIPARASITIC DRUGS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, IN 2024  61

FIGURE 24            NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD       62

FIGURE 25            NEW ZEALAND TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD       62

FIGURE 26            DEVELOPED MARKETS TO REGISTER HIGHER GROWTH THAN EMERGING MARKETS DURING FORECAST PERIOD                63

FIGURE 27            VETERINARY DERMATOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 65

FIGURE 28            PET POPULATION IN MAJOR MARKETS IN 2022 (MILLION)           66

FIGURE 29            EUROPE: PET POPULATION, 2021–2023  68

FIGURE 30            TOTAL INSURED PETS IN US, 2019–2023 71

FIGURE 31            TOTAL INSURED PETS IN CANADA, 2019–2023                 71

FIGURE 32            TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER, 2020–2023          74

FIGURE 33            NUMBER OF VETERINARIANS IN TOP 5 EUROPEAN COUNTRIES, 2023     75

FIGURE 34            VETERINARY DERMATOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS           82

FIGURE 35            DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS               84

FIGURE 36            PATENT PUBLICATION TRENDS, JANUARY 2014–DECEMBER 2024     88

FIGURE 37            TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014–DECEMBER 2024)                 89

FIGURE 38            TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014–DECEMBER 2024)              89

FIGURE 39            AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE,

2022–2024              92

FIGURE 40            AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES,

BY REGION, 2024               94

FIGURE 41            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE    97

FIGURE 42            KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS      97

FIGURE 43            VETERINARY DERMATOLOGY MARKET: ECOSYSTEM ANALYSIS  100

FIGURE 44            VETERINARY DERMATOLOGY MARKET: SUPPLY CHAIN ANALYSIS              104

FIGURE 45            VETERINARY DERMATOLOGY MARKET: VALUE CHAIN ANALYSIS              105

FIGURE 46            ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET            105

FIGURE 47            TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN

VETERINARY DERMATOLOGY MARKET 106

FIGURE 48            INVESTMENT AND FUNDING ACTIVITIES IN VETERINARY

DERMATOLOGY MARKET, 2020–2024       107

FIGURE 49            VETERINARY DERMATOLOGY MARKET, 2025–2030        172

FIGURE 50            GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA             174

FIGURE 51            NORTH AMERICA: PET POPULATION, 2024                 174

FIGURE 52           NORTH AMERICA: NUMBER OF VETERINARIANS, 2023        175

FIGURE 53            NORTH AMERICA: VETERINARY DERMATOLOGY MARKET SNAPSHOT    175

FIGURE 54            US: TOTAL PET HEALTH EXPENDITURE (2018–2024)      180

FIGURE 55            EUROPE: PET POPULATION (MILLION), 2023                 188

FIGURE 56            EUROPE: NUMBER OF VETERINARIANS, 2022                 188

FIGURE 57           ASIA PACIFIC: DOG POPULATION, BY COUNTRY, 2024        218

FIGURE 58            ASIA PACIFIC: CAT POPULATION, BY COUNTRY, 2024        218

FIGURE 59            ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET SNAPSHOT       219

FIGURE 60            LATIN AMERICA: PET POPULATION, 2022                 250

FIGURE 61            MIDDLE EAST & AFRICA: CAT POPULATION, 2024        265

FIGURE 62            REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020−2024)       286

FIGURE 63            SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2024)    287

FIGURE 64            RANKING OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2024 289

FIGURE 65            VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX, 2024  290

FIGURE 66            VETERINARY DERMATOLOGY MARKET: COMPANY FOOTPRINT, 2024      291

FIGURE 67            VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024                 298

FIGURE 68            VETERINARY DERMATOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     301

FIGURE 69            R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2021−2023          302

FIGURE 70            EV/EBITDA FOR TOP COMPANIES           302

FIGURE 71            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS            303

FIGURE 72            ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2024)      308

FIGURE 73            MERCK & CO., INC: COMPANY SNAPSHOT (2024)                 314

FIGURE 74            VIRBAC: COMPANY SNAPSHOT (2023)    320

FIGURE 75            ZOETIS INC.: COMPANY SNAPSHOT (2024)                 325

FIGURE 76            BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023)       331

FIGURE 77            VETOQUINOL: COMPANY SNAPSHOT (2023)                 335

FIGURE 78            DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2023)             338

FIGURE 79            HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT (2023)             342

FIGURE 80            PETIQ, INC.: COMPANY SNAPSHOT (2023)                 345

FIGURE 81            OUROFINO SAUDE ANIMAL: COMPANY SNAPSHOT (2023)             347

FIGURE 82            SWEDENCARE: COMPANY SNAPSHOT (2023)                 350

FIGURE 83            ORION CORPORATION: COMPANY SNAPSHOT (2023)    354

FIGURE 84            NORBROOK: COMPANY SNAPSHOT (2023)                 356

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• 沈降シリカ市場 – 2030年までの世界予測 2025-03-07
• スマートメーター市場 – 2030年までの世界予測 2025-03-07
• 産業用計測市場 – 2030年までの世界予測 2025-03-06
• 精密ろ過膜市場- 2029年までの世界予測 2025-03-06
• グリーンテクノロジーと持続可能性市場 – 2030年までの世界予測 2025-03-06

MarketsandMarkets  出版レポート一覧